An Integrated Meta-Analysis of Two Variants in HOXA1/HOXB1 and Their Effect on the Risk of Autism Spectrum Disorders by Song, Ran-Ran et al.
An Integrated Meta-Analysis of Two Variants in HOXA1/
HOXB1 and Their Effect on the Risk of Autism Spectrum
Disorders
Ran-Ran Song
1., Li Zou
2., Rong Zhong
2, Xia-Wen Zheng
2, Bei-Bei Zhu
2, Wei Chen
2, Li Liu
3*, Xiao-Ping
Miao
2*
1Department of Maternal and Child Health, School of Public Health, Tongji Medical College, Huangzhong University of Science and Technology, Wuhan, China,
2Department of Epidemiology and Biostatistics and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of
Science and Technology, Wuhan, China, 3Guangdong Key Lab of Molecular Epidemiology and Department of Epidemiology and Biostatistics, School of Public Health,
Guangdong Pharmaceutical University, Guangzhou, China
Abstract
Background: HOXA1 and HOXB1 have been strongly posed as candidate genes for autism spectrum disorders (ASD) given
their important role in the development of hindbrain. The A218G (rs10951154) in HOXA1 and the insertion variant in HOXB1
(nINS/INS, rs72338773) were of special interest for ASD but with inconclusive results. Thus, we conducted a meta-analysis
integrating case-control and transmission/disequilibrium test (TDT) studies to clearly discern the effect of these two variants
in ASD.
Methods and Findings: Multiple electronic databases were searched to identify studies assessing the A218G and/or nINS/
INS variant in ASD. Data from case-control and TDT studies were analyzed in an allelic model using the Catmap software. A
total of 10 and 7 reports were found to be eligible for meta-analyses of A218G and nINS/INS variant, respectively. In overall
meta-analysis, the pooled OR for the 218G allele and the INS allele was 0.97 (95% CI=0.76-1.25, Pheterogeneity=0.029) and
1.14 (95% CI=0.97-1.33, Pheterogeneity=0.269), respectively. No significant association was also identified between these two
variants and ASD risk in stratified analysis. Further, cumulative meta-analysis in chronologic order showed the inclination
toward null-significant association for both variants with continual adding studies. Additionally, although the between-
study heterogeneity regarding the A218G is not explained by study design, ethnicity, and sample size, the sensitive analysis
indicated the stability of the result.
Conclusions: This meta-analysis suggests the HOXA1 A218G and HOXB1 nINS/INS variants may not contribute significantly
to ASD risk.
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Introduction
Autism spectrum disorders (ASD) comprises a pervasive group
of neurodevelopmental disorders that share common features of
impaired social interaction, deviance in language development,
and stereotyped behaviors or narrow range of interests [1]. The
prevalence rate of ASD is 0.6%–1% in child and adolescent
populations, making it one of the most common disorders of
development in the world [2,3]. The etiology of ASD has been
debated ever since, but twin and family studies have highlighted
the genetic contribution to ASD, with a hereditability as high as
90% [4]. Converging lines of evidence pointed toward altered
prenatal neurodevelopment as being crucial to ASD pathogenesis,
suggesting a failure of development of at least one of the
rhombomeres, from which facial nucleus and superior olive arose
[4]. In this regard, one relied on available biological evidence that
genes encoding proteins involved in early neural development
could thus underlie this disease [4].
HOXA1 and HOXB1, located on chromosomes 7p and 17q, are
two paralogous genes in the HOX gene family of homeobox
transcription factors and critically involved in the developing
hindbrain during neural tube formation [5]. Evidence from
autopsy on brain of an idiopathic autism patient has showed the
near absence of the facial nucleus and superior olive [6], while the
facial nucleus and superior olive required normal HOXA1 and
HOXB1 function for their proper development. Similar morpho-
logic deficits in brain have been described in mice knockout Hoxa1
and Hoxb1 [7]. Moreover, Hoxa1 and Hoxb1 are highly expressed
during an early period of development overlapping with the
window of maximal prenatal sensitivity in rodent model [8]. These
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candidate genes for ASD. Ingram and his collaborators firstly
described variants in HOX genes for genetic susceptibility of ASD,
including an A to G substitution at base 218 (A218G, rs10951154)
of HOXA1 and a 9-base insertion variant (nINS/INS, rs72338773)
of HOXB1 [9]. Of these two candidate variants, the A218G in
HOXA1 changes a histidine (H) to arginine (R) at position 73
(H73R) and disrupted a string of histidine repeats in exon 1, while
the 9-base insertion c.82insACAGCGCCC (referred as INS allele)
in exon 1 of HOXB1 introduces into the amino acid sequence the
tripeptide histidine-serine-alanine (H-S-A) [10]. Ingram et al.
firstly reported significant deviations from Hardy-Weinberg
equilibrium for A218G of HOXA in 57 autistic probands and
119 unrelated adults as controls, indicating that the G allele
carriers might be susceptible to ASD [9]. Interestingly, interaction
among HOXA1, HOXB1, and gender was also found to be
associated with increased risk of ASD [9]. After this first report, a
string of studies have subsequently detected these two variants of
HOXA1 and HOXB1 in ASD, but the results were inconsistent.
Inversely, Conciatori et al. pointed out the A allele, not the G
allele, was associated with ASD risk in both case-control and
family-based association analyses [11]. Additionally, some re-
searches failed to replicate the findings by Ingram et al.
[10,12,13,14,15,16,17,18,19]. The sample size of any individual
study tended to be small and thus potentially leaded to imprecise
estimates and inconsistent results for these two variants in ASD.
Nevertheless, meta-analysis, due to its exponential increase in
sample size, may be a powerful tool to clarify the inconsistent
findings in genetic association studies by statistical synthesis of data
if properly used [20]. Furthermore, the transmission/disequilibri-
um test (TDT) based on family is particularly advantageous as less
confounding caused by population admixture and is of the same
importance as case-control study in genetic association analysis
[21]. However, it might be a little statistically challenging to
synthesis the family-based studies with case-control studies before
Kazeem et al. outlined a methodological improvement for
achieving integration of these two different types of studies by a
fixed-effects approach, using an allele-based mode [22], and then
Nicodemus subsequently extended this method to the random-
effects model [23]. Therefore, we conducted a meta-analysis of
published studies and applied the method described by Kazeem et
al. [22] to integrate the results from case-control and TDT studies
to provide more precise evaluation for the association of HOXA1
and HOXB1 genetic variants with ASD risk.
Methods
To ensure the rigour of this current meta-analysis, we designed
and reported it according to the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) [24] statement
and the checklist is shown in table S1 (http://www.prisma-
statement.org).
Search strategy and identification of relevant studies
We searched PubMed, EMBASE, and ISI Web of Science
databases for published articles up to August 2010, which had
investigated at least one of A218G in HOXA1 and insertion variant
in HOXB1 associated with ASD in case-control study or TDT
study. The search strategy was based on combinations of the
keywords ‘HOXA1, homeobox A1, HOXB1 or homeobox B1’,
‘polymorphism or variant’ and ‘autism or autistic disorder’
without language restrictions. To expand the coverage of our
searches, we further performed searches in Chinese Biomedical
(CBM) database using the above searching strategy. References of
the retrieved articles were also scanned. Reviews, comments, and
letters were also checked for additional studies.
The inclusion criteria had to be fulfilled: (1) either case-control
or TDT study design; (2) data on any or both polymorphisms of
A218G in HOXA1 and insertion variant in HOXB1; (3)
presentation of data necessary for calculating odds ratios (ORs);
(4) clear definition of ASD. Animal studies, reviews, simply
commentaries, case reports and unpublished reports were
excluded. Study overlapping with other studies should be
eliminated, and the report with complete design or larger sample
size was finally selected.
Data extraction
All data were extracted independently by two reviewers (R–R.
Song & L. Zou). The following information was extracted from the
eligible studies: first author’s name, year of publication, ethnicity,
design type of study, and diagnostic criteria for ASD. Counts of
alleles in case and control group in case-control studies and
numbers of transmitted alleles from heterozygous parents to
affected offspring in family-based studies were extracted or
calculated from published data in the included studies.
Statistical analysis
Data from case-control studies were summarized in two-by-two
tables, and data from TDT studies were summarized in two-by-one
tables. ORs and their 95% confidence intervals (CIs) and standard
errors (SEs) were calculated for individual study based on the allele
data using the method as described by Kazeem et al. [22]. The x
2-
based Cochran’s Q statistic test was employed to test between-study
heterogeneity, and heterogeneity was considered significant when
P,0.1 for Q statistic. Data from the studies were combined by the
random-effects model when heterogeneity was significantly present;
otherwise, fixed-effects model was applied. For the synthesis of case-
control and TDT studies, the method described by Kazeem et al.
was used [22]. After obtain the estimate of logarithm of the OR and
its associated SE in each case-control or TDT study, the estimate of
combined OR andits associated SEcanbe calculatedbya weighted
analysis method [25]. The Catmap software implemented this
method for the fix-effects model and plus extended this method for
the random-effects model of DerSimonian and Laird to conduct
case-control and TDT meta-analysis, which can be download from
the comprehensive R network http://www.r-project.org [23].
Overall meta-analysis was initially performed. Then stratified
analysis, if feasible, was performed according to study design,
sample size, and ethnicity separately. Publication bias was assessed
by funnel plot and Egger’s test [26]. Additionally, sensitivity analysis
was also performed to assess the influence of each study on the
overall estimate. Cumulative meta-analysis was also conducted via
the assortment of studies by publication time. All P values are two-
tailed with a significant level at 0.05. All statistical analyses were
carried out in Catmap software V1.6.
Results
Characteristics of included studies
Figure 1 shows theliterature search and study selection procedures.
After comprehensive searching, 23 potentially relevant reports were
retrieved, of which, 12 reports met the inclusion criteria. However,
the study reported by Muscarella et al. in 2007 [16] was excluded
since the cases largely overlapped with the sample in analysis by
Conciatori et al. [11]. A total of 11 reports were ultimately eligible for
this meta-analysis [9,10,11,12,13,14,15,17,18,19,27]. Additionally,
since 5 reports applied a double approach comprising case-control
and TDT designs in the same or overlapping probands
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excluded in the overall meta-analysis due to less sample size than
TDT studies. Therefore, 10 reports comprising 113 cases, 184
controls and 958 families were relevant to A218G in HOXA1,a n d7
reports including 113 cases, 184 controls and 570 families were
relevant to insertion variant in HOXB1. Table 1 shows the
characteristics of the included studies.
Combining results of case-control and TDT studies
Figure 2A shows the combined result of case-control and TDT
studies for A218G in association with ASD. Heterogeneity was
found among the 3 case-control and 10 TDT studies from 10
reports (x
2=22.83, Pheterogeneity=0.029); thus, the random-effects
model was employed. Pooled OR and 95% CI were calculated for
the 218G allele versus the 218A allele. However, no significant
association was found between the allelic variant and ASD risk
(OR=0.97, 95%CI=0.76-1.25, P=0.843). For HOXB1 nINS/
INS variant, no evidence of heterogeneity was presented among
the 3 case-control and 5 TDT studies from 7 reports (x
2=8.78,
Pheterogeneity=0.269). In the fixed-effects model, this insertion
variant was not significantly associated with risk of ASD
(OR=1.36, 95%CI=0.97-1.33, P=0.118; Figure 2B).
Stratified analysis
The stratified analysis was firstly performed by study design. In
case-control studies, evidence of between-study heterogeneity was
Figure 1. Flow diagram of the study selection procedure.
doi:10.1371/journal.pone.0025603.g001
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2=13.14, Pheterogeneity=0.069;
Table 2). The pooled allelic OR in the random-effects model
was 0.91 (95%CI=0.67-1.26, P=0.588). There was no indication
of heterogeneity for HOXB1 variant (x
2=8.83, Pheterogeneity=
0.116; Table 3). The pooled OR of the INS allele versus nINS
allele in the fixed-effects model was 1.13 (95%CI=0.90-1.42,
P=0.284). In TDT studies, the heterogeneity test for A218G
showed positive results (x
2=21.13, Pheterogeneity=0.012). In the
random-effect model, this variant presented no association with
ASD risk (OR=0.98, 95%CI=0.74-1.31, P=0.900). No sign of
heterogeneity was detected for HOXB1 insertion variant (x
2=1.34,
Pheterogeneity=0.854), and no significant association between ASD
and this variant was found in the fixed-effects model (OR=1.16,
95%CI=0.98-1.38, P=0.079).
The data were further stratified by sample size into 2 subgroups,
the large-sample-size subgroup (number of cases in case-control
study or number of family in family-based study .80) and the
small- or moderate-sample-size subgroup (number of cases in case-
control study or number of family in family-based study #80).
Heterogeneity was detected for A218G in the large-sample-size
subgroup including 5 TDT studies (x
2=10.10, Pheterogeneity=
0.039) but not in the small-sample size subgroup including 3 case-
control studies and 5 TDT studies (x
2=7.90, Pheterogeneity=0.342).
No significant association between A218G and ASD risk was
found in the small- or large-sample size subgroup (OR=1.22,
95%CI=0.93-1.62 and OR=0.83, 95%CI=0.68-1.03, respec-
tively). For HOXB1 insertion variant, no significant associations
were observed in both the large-sample-size subgroup including 3
TDT studies (OR=1.14, 95% CI=0.94-1.36, Pheterogene-
ity=0.733) and the small-sample size subgroup including 3 case-
control studies and 2 TDT studies (OR=1.14, 95% CI=0.83-
1.57, Pheterogeneity=0.090).
In terms of ethnicity, the data were stratified into Whites,
Blacks, Yellows, and Indians. No statistically significant finding
was seen in Whites for A218G or nINS/INS variant. The pooled
OR for the former was 0.92 (95% CI=0.55-1.54, Pheterogeneity=
0.002) and the latter was 1.17 (95% CI=0.95-1.47, Pheterogeneity=
0.719). The pooled OR could not be appraised in Blacks, Yellows,
and Indians because of limited numbers of studies conducted in
these populations.
Sensitivity analyses for combined studies of HOXA1
polymorphism
Given the significant between-study heterogeneity for HOXA1
A218G polymorphism, we conducted a sensitive meta-analysis to
assess the effects of each individual study on the combined OR. A
random-effect model was employed since heterogeneity was
indicated. A series of combined OR with 95% CIs produced
repeatedly after removal of each particular study consistently
encompassed 1.0, suggesting the stability of the outcome that
A218G was not associated with ASD risk (Table 4). Additionally,
sensitivity analyses indicated that TDT study conducted in Italian
families by Conciatori et al. [11] was the main origin of the
heterogeneity for HOXA1 variant. The P value for Q test was not
less than 0.1 after deletion of this study by Conciatori et al.
(x
2=19.99, Pheterogeneity=0.130), but the effect of 218G still lacked
of significance (OR=1.03, 95% CI=0.89-1.19, P=0.67).
Cumulative meta-analyses
Cumulative meta-analyses of these two variants were also
conducted via assortment of studies in chronologic order.
Figure 3A and Figure 3B show the results from the cumulative
meta-analyses for the HOXA1 A218G in the random-effects model
and the HOXB1 nINS/INS in fixed-effects model. The effect of
Table 1. Characteristics of included studies.
Study
Publication
Year Ethnicity Design type
Control matched
condition
Case/control
(family)
Diagnostic
criteria
Ingram [9] 2000 White Case-control Ethnicity 57/119 DSM-IV
Ingram [9] 2000 White Family – 50 DSM-IV
Li [17] 2002 Mixed Family – 110 ADI/ADOS
Devlin [18] 2002 Mixed Family – 221 DSM-IV
Talebizadeh [13] 2002 Mixed Case-control Ethnicity 35/35 DSM-IV
Collins [19] 2003 White Case-control Ethnicity 128/132 DSM IV-R
Collins [19] 2003 Black Case-control Ethnicity 64/127 DSM IV-R
Collins [19] 2003 72.7% White; 27.3% Black Family – 187 DSM IV-R
Romano [15] 2003 White Case-control Ethnicity HOXA1:85/132
HOXB1:80/80
DSM-IV
Romano [15] 2003 White Family – 85 DSM-IV
Conciatori [11] 2004 White Case-control Ethnicity 127/174 DSM-IV
Conciatori [11] 2004 White (Italian) Family – 115 DSM-IV
Conciatori [11] 2004 White (American) Family – 74 DSM-IV
Gallagher [10] 2004 White Family – 78 ADI/ADOS
Yu [12] 2004 Yellow Family – 38 ICD-10
Sen [14] 2007 Eastern Indian Case-control Ethnicity 62/89 DSM-IV
Sen [14] 2007 North Indian Case-control Ethnicity 16/60 DSM-IV
Muscarella [27] 2010 White Case-control Ethnicity 169/184 DSM-IV
Muscarella [27] 2010 White Family – 247 DSM-IV
doi:10.1371/journal.pone.0025603.t001
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association over time. Moreover, the 95% CIs became increasingly
narrower with increasing data, suggesting that the precision of the
estimates was progressively enhanced by continual adding more
studies.
Publication bias
As reflected by funnel plots (Figure S1 and Figure S2) and
Egger’s test, there was no publication bias for A218G and nINS/
INS variants (P=0.564 and 0.591, respectively).
Discussion
This current meta-analysis included 113 cases, 184 controls, and
958 families concerning the A218G in HOXA1 and 113 cases, 184
controls, and 570 families concerning the insertion variant in
HOXB1. Both the A218G and nINS/INS variants showed no
significant association with risk of ASD. This current meta-
analysis, to the best of our knowledge, firstly integrated the case-
control and TDT studies to reflect the precision effect of HOXA1
and HOXB1 variants in ASD risk.
HOXA1 is a critical member of HOX gene family involved in
the development of hindbrain [5]. Given the critical role in
development of brain stem, HOXA1 was of special interest in
ASD. In the HOXA1 gene, the A218G variant causing a
histidine to arginine has been shown to disrupt the string of
histidine repeats, which was believed to be the binding site of
other proteins [9]. According to the function of this variant,
studies continuously measure this variant in ASD risk, but with
mixed or conflicting results. In this meta-analysis, neither the
overall combined analysis nor the stratified analysis showed
association between A218G and ASD with evidence of
heterogeneity. To explore the source of heterogeneity, we
further conducted stratified and sensitive analyses. Analysis
stratified by sample size suggested that the heterogeneity was
only presented in the large-sample-size subgroup, while sensitive
analysis showed the heterogeneity was effectively removed after
deletion of the TDT study in Italian by Conciatori et al. [11].
Interestingly, the large-sample-size subgroup comprised this
TDT study by Conciatori et al., indicating this report was the
main origin of the heterogeneity. Under review of this report,
Conciatori et al. indicated a contradictory result to other
included studies that the 218A allele, not the 218G allele,
increased risk of ASD. After removing this study, the A218G
variant still lacked significance in ASD. Moreover, effect
estimates did not change significantly after in turn removing
other studies, indicating the stability of this current result. The
cumulative analysis gave further support to this current result by
Figure 2. Summary estimates (Odds ratios and 95% confidence intervals) for risk of ASD associated with HOXA1/HOXB1 variants. (A)
ASD risk for HOXA1 A218G: random-effects pooled OR=0.97, 95%CI=0.76-1.25, P=0.843; x
2=22.83, Pheterogeneity=0.029. (B) ASD risk for HOXB1 nINS/
INS: fixed-effects pooled OR=1.14, 95%CI=0.97-1.33, P=0.118; x
2=8.78, Pheterogeneity=0.269. Abbreviations: CC, case-control study; TDT,
transmission/disequilibrium test.
doi:10.1371/journal.pone.0025603.g002
Table 2. Meta-analysis of case-control and TDT studies between the A218G in HOXA1 and ASD.
Study ID Case-control TDT OR(95%CI)
Cases Controls Transmitted G Non-transmitted G Case-control TDT
A/G A/G
Ingram, 2000 [9] - - 30 16 - 1.88 (1.02-3.44)
Ingram, 2000 [9] 91/23 212/26 - - 2.06 (1.12-3.80) -
Li, 2002 [17] - - 54 50 - 1.08 (0.74-1.59)
Devlin, 2002 [18] - - 63 76 - 0.83 (0.59-1.16)
Talebizadeh, 2002 [13] 58/12 54/16 - - 0.70 (0.30-1.61) -
Collins (White), 2003 [19] - - 18 29 - 0.62 (0.34-1.12)
Collins (Black), 2003 [19] - - 18 16 - 1.13 (0.57-2.21)
Collins (White), 2003 [19] 215/41 220/44 - - 0.95 (0.60-1.52) -
Collins (Black), 2003 [19] 59/69 110/144 - - 0.89 (0.58-1.37) -
Romano, 2003 [15] - - 19 15 - 1.27 (0.64-2.49)
Romano, 2003 [15] 150/20 224/40 - - 0.75 (0.42-1.33) -
Conciatori (Italian), 2004 [11] - - 11 31 - 0.35 (0.18-0.71)
Conciatori (American), 2004 [11] - - 12 17 - 0.71 (0.34-1.48)
Conciatori, 2004 [11] 237/17 304/44 - - 0.50 (0.28-0.89) -
Gallagher, 2004 [10] - - 24 15 - 1.60 (0.84-3.05)
Yu, 2004 [12] - - 9 5 - 1.80 (0.60-5.37)
Sen (Eastern Indian), 2007 [14] 116/8 166/12 - - 0.95 (0.38-2.41) -
Sen (Northern Indian), 2007 [14] 30/2 117/3 - - 2.60 (0.42-16.27) -
Total 956/192 1407/329 258 270 0.92
a (0.67-1.26) 0.98
b (0.74-1.31)
aRandom-effects pooled OR, P=0.588; x
2=13.14, Pheterogeneity=0.069.
bRandom-effects pooled OR, P=0.900; x
2=21.13, Pheterogeneity=0.012.
doi:10.1371/journal.pone.0025603.t002
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ation after 2002 over time. In view of these, we are convinced
that the result of the null-significant association between A218G
variant and ASD is sound and reliable.
HOXB1, in conjunction with HOXA1, partly determined the
placement of hindbrain segments in the proper location along the
anterior-posterior axis during embryo development [5]. A 9-bp
insertion variant, located in the amino-terminal coding region and
introduces the tripeptide histidine-serine-alanine in the exon 1
of the HOXB1 gene [28], has been investigated by multiple
studies in relation to ASD risk, but results were conflicting
[9,10,13,14,15,17,27]. In this study, no significant association of
this HOXB1 variant and ASD was identified in overall meta-
analysis or stratified analyses by study design, sample size, and
ethnicity under fixed-effect model. The cumulative analysis further
reported the null-significant association tended to be stable as the
number of studies and the sample size increased, conceivably
suggesting no association of HOXB1 variant with ASD risk.
Integrating case-control and family based studies is an
important aspect of genetic analysis, and combined estimates
can provide an overall picture of the effect size attributable to
genetic polymorphism. An illustrative application has been made
by Gong et al. to Neuregulin 1 polymorphisms in schizophrenia [29].
In this meta-analysis, when the case-control and family studies
were appraised independently, no significant association was
found for the HOXA1 or HOXB1 variant, indicating the statistical
consistency between these two types of studies. When the case-
control studies were combined with family studies, statistical power
was enhanced from enlargement of sample size, and the ORs and
P values stably showed the null-significant associations. This meta-
analysis integrating case-control with family-based studies there-
fore provides a straightforward mean to increase the ability to
clarify the conflicted results of genetic studies.
Despite the clear strength of this study integrating case-control
and family studies, some limitations merit serious consideration.
Some heterogeneous natures of studies, including mixed popula-
tion samples, variant age range of controls in case-control design,
multiplex or simplex trios utilized in family studies, possibly have
effect on the current result. However, due to lack of detail data or
limited small number of some studies, we were unable to perform
further analysis. Given the HOXB1 and HOXA1 genes have
synergized in patterning hindbrain structures, there was a
hypothesis that gene-gene interaction between HOXA1 and
HOXB1 variants might be involved in ASD. However, interaction
of these two variants could not be appraisal in this meta-analysis
because of a lack of special data.
In conclusion, this meta-analysis helped for strongly clarifying
the discrepancies of genetics studies into associations of HOXA1
Table 4. Sensitivity analysis of pooled OR combining family-
based and case-control studies for HOXA1 A218G
polymorphism.
Study omitted OR (95%CI) P
a P
b
heterogeneity
Ingram (TDT), 2000 [9] 0.91 (0.72-1.16) 0.456 0.088
Li, 2002 [17] 0.96 (0.72-1.29) 0.805 0.022
Devlin, 2002 [18] 1.00 (0.75-1.34) 0.991 0.025
Talebizadeh, 2002 [13] 1.00 (0.77-1.30) 0.984 0.022
Collins (White, TDT), 2003 [19] 1.02 (0.78-1.33) 0.884 0.038
Collins (Black, TDT), 2003 [19] 0.96 (0.73-1.26) 0.794 0.020
Romano (TDT), 2003 [15] 0.95 (0.73-1.25) 0.733 0.023
Conciatori (Italian TDT), 2004 [11] 1.04 (0.84-1.29) 0.698 0.216
Conciatori (American TDT), 2004 [11] 1.00 (0.77-1.31) 0.998 0.023
Gallagher, 2004 [10] 0.93 (0.72-1.20) 0.591 0.042
Yu, 2004 [12] 0.95 (0.73-1.22) 0.693 0.028
Sen (Eastern Indian), 2007 [14] 0.98 (0.75-1.27) 0.867 0.019
Sen (Northern Indian), 2007 [14] 0.96 (0.74-1.23) 0.743 0.027
Abbreviations: TDT, transmission/disequilibrium test.
aDerSimonian and Laird Random-effects model used to determine the
significance of the overall OR.
bCochran’s x
2-based Q statistic test used to assess the heterogeneity.
doi:10.1371/journal.pone.0025603.t004
Table 3. Meta-analysis of case-control and TDT studies between the insertion variant in HOXB1 and ASD.
Study ID Case-control TDT OR(95%CI)
Cases Controls Transmitted INS Non-transmitted INS Case-control TDT
nINS/INS nINS/INS
Ingram, 2000 [9] - - 32 22 - 1.45 (0.85-2.50)
Ingram, 2000 [9] 85/29 186/52 - - 1.22 (0.72-2.06) -
Li, 2002 [17] - - 86 74 - 1.16 (0.85-1.59)
Talebizadeh, 2002 [13] 53/17 55/15 - - 1.18 (0.53-2.59) -
Romano, 2003 [15] - - 30 22 - 1.36 (0.79-2.36)
Romano, 2003 [15] 126/34 124/36 - - 0.93 (0.55-1.58) -
Gallagher, 2004 [10] - - 14 12 - 1.17 (0.54-2.52)
Sen (Eastern Indian), 2007 [14] 110/14 144/34 - - 0.54 (0.28-1.05) -
Sen (Northern Indian), 2007 [14] 26/6 111/9 - - 2.85 (0.93-8.70) -
Muscarella, 2010 [27] - - 127 118 - 1.08 (0.84-1.38)
Muscarella, 2010 [27] 262/76 303/65 - - 1.35 (0.93-1.96) -
Total 662/176 923/211 289 248 1.13
a (0.90-1.42) 1.16
b (0.98-1.38)
aFixed-effects pooled OR, P=0.284; x
2=8.83, Pheterogeneity=0.116.
bFixed-effects pooled OR, P=0.079; x
2=1.34, Pheterogeneity=0.854.
doi:10.1371/journal.pone.0025603.t003
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PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e25603and HOXB1 variants with ASD, and suggest null association of
the A218G and nINS/INS variants with ASD risk. Further
analysis should be imposed in possible interaction effect between
HOXA1 and HOXB1 genetic polymorphisms in modulation of
ASD risk.
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